Back to Authors

She, Rosemary C.

https://orcid.org/0000-0002-8773-1687

Mayo Clinic

City Of Hope National Medical Center

Citations 4

Diagnostic testing and laboratory equity in clinical microbiology
Larkin, Paige M. K. , Theel, Elitza S. , Culbreath, Karissa , Garner, Omai B. , Vassell, Shannon, Kim, Wes , She, Rosemary C. , Long, S. Wesley , Babady, N. Esther , Wesley Long, S , Babady, Esther , Kim, Wes

Microbiology Spectrum | June 25, 2024 | Volume: 12 | Issue: 8 | Pages: No page available

10.1128/spectrum.01222-24 Get It

Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status
Peaper, David R. , Rhoads, Daniel D. , Sullivan, Kaede V. , Couturier, Marc Roger , Humphries, Romney M. , Nolte, Frederick S. , Rowlinson, Marie‐Claire , She, Rosemary C. , Simner, Patricia J. , Theel, Elitza S. , Wojewoda, Christina , Nolte, Frederick S , Simner, Patricia J , Theel, Elitza S , Wojewoda, Christina M , Humphries, Romney , Rhoads, Daniel D , Martin, Isabella W.

Journal of Clinical Microbiology | July 14, 2021 | Volume: 59 | Issue: 10 | Pages: No page available

10.1128/jcm.01167-21 Get It

The U.S. Food & Drug Administration (FDA) regulates the marketing of manufacturers’ in vitro diagnostic tests (IVDs), including assays for the detection of SARS-CoV-2.
College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value
Rhoads, Daniel D. , She, Rosemary C. , Nolte, Frederick S. , Wojewoda, Christina , Anderson, Neil W. , Pritt, Bobbi S. , Pritt, Bobbi S , Rhoads, Daniel D , Peaper, David R.

Clinical Infectious Diseases | August 11, 2020 | Volume: 72 | Issue: 10 | Pages: e685-e686

10.1093/cid/ciaa1199 Get It